Mink Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Mink Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mink Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mink Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $96 | 129 | 0.75 |
| 2024-06-30 | $102 | 107 | 0.95 |
| 2024-03-31 | $96 | 107 | 0.91 |
| 2023-12-31 | $115 | 107 | 1.07 |
| 2023-09-30 | $124 | 107 | 1.17 |
| 2023-06-30 | $224 | 107 | 2.10 |
| 2022-06-30 | $0 | 247 | 0.00 |
| 2022-03-31 | $2.0k | 941 | 2.13 |